GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex)

Scientific Overview, Mechanism, Clinical Use and Evidence

Scientific Overview

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. It functions as a signaling molecule involved in tissue repair, extracellular matrix remodeling, anti-inflammatory regulation, and antioxidant defense. GHK-Cu has been extensively studied in dermatology, wound healing, and regenerative medicine and represents one of the best-characterized peptides in clinical aesthetics.

Mechanism of Action

GHK-Cu binds copper (II) ions and delivers them to tissues, where the complex modulates gene expression and enzymatic activity. Key mechanisms include:

• Upregulation of collagen I and III synthesis
• Stimulation of fibroblast proliferation and migration
• Promotion of angiogenesis and wound healing
• Downregulation of pro-inflammatory cytokines and matrix metalloproteinases
• Enhancement of antioxidant enzymes such as superoxide dismutase

Gene expression studies demonstrate that GHK-Cu influences hundreds of genes involved in tissue regeneration and anti-aging pathways.

Biological and Clinical Effects

Preclinical and human studies demonstrate that GHK-Cu accelerates wound healing, improves skin elasticity and thickness, reduces fine lines and wrinkles, and supports hair follicle function. In dermatologic and aesthetic medicine, GHK-Cu is widely used for skin rejuvenation, post-procedure recovery, and treatment of photoaging.

Time of Use / Treatment Duration

Injectable protocols commonly describe cycles of 4–8 weeks, followed by reassessment or maintenance strategies. Topical use may be continuous, with gradual improvements observed over weeks to months of consistent application.

Safety, Tolerability, and Precautions

GHK-Cu demonstrates an excellent safety profile in topical and injectable use. Adverse effects are typically limited to mild, transient local reactions such as erythema or discomfort at injection sites. Use during pregnancy and lactation is generally avoided due to limited safety data.

Detailed References

Pickart L & Thaler MM. (1973). Tripeptide in human serum that restores aged fibroblast growth. Nature, 243, 85–87.

Maquart FX et al. (1993). Stimulation of collagen synthesis by the tripeptide-copper complex GHK-Cu. FEBS Letters, 328(1–2), 155–160.

Simeon A et al. (2000). Copper peptide-induced wound healing. Journal of Investigative Dermatology, 114(4), 606–612.

Pickart L. (2008). The human tri-peptide GHK and tissue remodeling. Biogerontology, 9(6), 393–405.

Pickart L et al. (2015). Gene expression changes induced by GHK-Cu. Journal of Aging Research.

LaValle J. The Complete Guide to Peptides. Clinical use of copper peptides in regenerative and aesthetic medicine.

Posology (Clinical Practice–Oriented)

Commonly described clinical approaches include:

• Injectable (SC or intradermal): 1–5 mg per session, weekly or biweekly
• Topical: daily application of creams or serums containing GHK-Cu

Use should be individualized based on skin goals, tolerability, and practitioner experience.

Clinical Practice Framing

In integrative, regenerative, and aesthetic medicine, GHK-Cu is positioned as a foundational regenerative peptide rather than a hormonal or systemic therapy. GHK-Cu is most effective when combined with nutritional support, antioxidant strategies, procedural dermatology, and lifestyle measures that reduce oxidative and inflammatory burden.

The peptides described in this material are intended strictly for research purposes only. They are not approved for human or veterinary use, clinical application, diagnosis, treatment, or prevention of any disease.

Any research involving these compounds must be conducted in compliance with applicable laws and regulations in the country where the research is performed, including prior approval by a duly constituted Ethics Committee or Institutional Review Board (IRB), where required.

RegenPept acts solely as a supplier of research-grade materials and assumes no responsibility or liability for the design, conduct, regulatory compliance, interpretation, or outcomes of any research involving these products.

Any dosage, administration protocols, or related information contained in this material are derived from publicly available scientific literature and are provided strictly for informational purposes. Such information does not constitute medical advice, therapeutic recommendation, or endorsement of any specific use by RegenPept.